Yearly Archives: 2015
The risk of death from high-risk prostate cancer in men undergoing EBRT and brachytherapy
According to the National Comprehensive Cancer Network (NCCN) guidelines, treatment with long-course (28–36 months) androgen deprivation therapy (ADT), in addition to brachytherapy (where radioactive seeds are implanted inside the prostate to kill cancer cells) and external beam radiation










